{"name":"Wuhan YZY Biopharma Co., Ltd.","slug":"wuhan-yzy-biopharma-co-ltd","ticker":"","exchange":"","domain":"yzybio.com","description":"","hq":"Wuhan","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"M701 pleural infusion","genericName":"M701 pleural infusion","slug":"m701-pleural-infusion","indication":"Other","status":"phase_1"},{"name":"paracentesis","genericName":"paracentesis","slug":"paracentesis","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"M701","genericName":"M701","slug":"m701","indication":"Advanced solid tumors (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"M701","genericName":"M701","slug":"m701","phase":"phase_3","mechanism":"M701 is a bispecific antibody that simultaneously engages two distinct immune checkpoints to enhance anti-tumor T cell responses.","indications":["Advanced solid tumors (Phase 3 development)"],"catalyst":""},{"name":"M701 pleural infusion","genericName":"M701 pleural infusion","slug":"m701-pleural-infusion","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"paracentesis","genericName":"paracentesis","slug":"paracentesis","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5NZkZlc3l0VTRHTkZIcEE1NGlUTDhHY2lnbGVtMzNSSGY2YVdpUnRYaFVPWnNGaE9BR1dsZkVCTS1Bb2lub3oyM1BIckNuRE0xbEZRLWNlSEpiamo2QXN0VEUtUGxkMWlBeDdmZw?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore","headline":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxONktOQTZBdW9sLXdQUHV5RU5sUFRMMUpwQ0pSRFZuUVBkMGQ5M0M4OUJKdVpneGdxc2pKM1hpaGs0Qmw4dExmbjRrUnUwM2FoclkwYkQ4UWJ3M011M1ZCQ2NxMU9WN25xYmVIejR6dW9qY0hZYUFGaTVtNEI4ZWhLUlc4MkJ6MkxZZ1U5Q2o3dEROYjJMdVpQaHEzNFBMMXE4XzNFSnNDQ2lzd0t1RGc3WjdZY3JkNzd4czJFdEdXZGpnaUd1d21NZmRTeVZKMXN1dlRKQVdEODRMaXlIdFJKMEVURm1xVHdMbDNoa1dn0gHzAUFVX3lxTE1DeFBOcDFtVTBiS3lUMDFDTkRvWUtqSWI3aWIwY2RYcmx1YnhJMUUyYl9SdXNkYWl4TUVVNzJLb3pFZ3dvc2psLWhJZ2RYdlNVQk9LbFJSd2lGZnVEd0tXS3FfMGx3andhMFpmVl91eEF4YVRVN3RaRzl2cVQ5Y1I5ZTctcU9IVlA0b1RsUHNGY29uMENlaDFFY2pRNW9vYkktUG1LdmZPVjBCRUluMkM4Z3k3cWQ4bjVHWk9GakNsemxwRUN2NG1DanVRa3JCd1JYM3IwdkRpMzNMcUNZZmNPajJMa0FROVM4X1JNem54UnlHYw?oc=5","date":"2026-03-29","type":"pipeline","source":"simplywall.st","summary":"Wuhan YZY Biopharma (SEHK:2496) Loss Deepens In 1H 2025 Challenging Improving Loss Trend Narrative - simplywall.st","headline":"Wuhan YZY Biopharma (SEHK:2496) Loss Deepens In 1H 2025 Challenging Improving Loss Trend Narrative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOWWxfS09IWW5kYlBXcXlUMUFqeHRORHJWR1Faa3FGN3RjZ216NEVYdF8wY01qblcxNlJKWVR4Y21WOWpuWU9KNU1aN3o2REpBejIzZV9SV2VxTlc4a2ZZSHFVbFg0RGpDdC1ZOHpoN1c0Q2stNXpBN1h1VmtTUWRReVozVnFSWHpzTm5pdTd5Q3ZTYnFsSUJldXlXVHdJWjFlaXJKS3JGaEVGbC1GbnVLTWk4azhlNlc5Q04xWXc2ajdLNjVv?oc=5","date":"2026-03-17","type":"regulatory","source":"TipRanks","summary":"Wuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results - TipRanks","headline":"Wuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9wVEVWOEFSaXpIWmJGTXJaREVfYWw3X055bFYzYk52azZ5S0o4Tlh2V3pYRjJOQWdMR05uMjR4b2FGU0liakFXWjZIYVZrQlF2N0FtRGd3?oc=5","date":"2025-07-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Nanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Nanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPQWVLaTBhTFI3LXo4NDA4Tnoza2dKczVxcjlqdkczcDlOVF9iblZnLUJpSzRxVHFlaWVqd0VYLW81bmU1Z0dzMk1pbF9BU0lKZmo0VU1kVEI1c0duZW1qNXM4cUJxa1dpVzRXYnl4OTlXSnBlQ2RfWXFoNWJBWENvMllhb2s2N1hOT1Q0bVpqLUdUS2locFFMVUt3ZFhKbG96bTl2Sjhabw?oc=5","date":"2024-01-25","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPO class of 2023 ends the year with performance up 7% - BioWorld News","headline":"Biopharma IPO class of 2023 ends the year with performance up 7%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9NbFNsTEhxbGJDYmNGaE9IWW95ZS1NZDBrTl9WanVZem0zZE5CNDJSX3NsTEd4VmtpOXMwQ3NkR0gtODRsOUNsM3ZHWTJnM3p3NnVZVklR?oc=5","date":"2022-03-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Sirnaomics Ltd. (2257.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Sirnaomics Ltd. (2257.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE53ZDY1VWtZUnF1MnNpSWJqS0xnOXJ5SjhtQXI2a2Y1blVRb3hVUS0yRk9hWDlxM1FQaVE4andPenNNQmNpb0Y4QVBraE9TbXgzVFFkOTZR?oc=5","date":"2021-07-28","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Keymed Biosciences Inc. (2162.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Keymed Biosciences Inc. (2162.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE85NFNWOWM5dFRfRENtc0FvNkZTVjcwOVlrMmpzOF94WEx5ZmFMOUdONDA0UU02amtKTTh2a2hqWFlIR1R1TGhzMG55Zl96NUEteUJueURB?oc=5","date":"2021-02-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Pharmaron Beijing Co., Ltd. (3759.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Pharmaron Beijing Co., Ltd. (3759.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5pSFZmMG94M0xwZEJmMllab2ZFN0ZVeFUxQ2hfbFdhSGF4amZDdVU2elpSaHYzM3JTN3NzLVdLMC0xZVJVRGdDRGRkQUlDX1RyTmtkbmpR?oc=5","date":"2020-09-20","type":"pipeline","source":"Yahoo Finance UK","summary":"Immunotech Biopharm Ltd (6978.HK) stock price, news, quote and history - Yahoo Finance UK","headline":"Immunotech Biopharm Ltd (6978.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPb0hoc05sM2Y2bDJEYXZyMktyU0VScHpabVB3cnpyZjEzc2dPUzJyYXF4cjg1aXJHLXBIQjFJcV84bU55YTlEY2Z4czJWeENWemIzc3ZHM0xYNmZZOVJxVHNnZi1VUnU2QXlWX3hySTQxMllnWDhDb21PejQ1d0FKNndOZDhJRGZQMW9xNzJHLUFRTHF0bUtfbWx3?oc=5","date":"2017-11-05","type":"pipeline","source":"hkex.com.hk","summary":"China Dimension - hkex.com.hk","headline":"China Dimension","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"phase_1":1,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}